abstract |
The invention relates to derivatives of azetidine and cyclobutane, as well as their compositions, methods of use and methods of production, with these derivatives are inhibitors of JAK-kinases, suitable for the treatment of JAK-mediated diseases, including, for example, inflammatory and autoimmune disorders, as well as cancer . |